Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3‐Phenyl‐1,4‐benzothiazine Analogues
暂无分享,去创建一个
G. Kaatz | B. Schindler | S. Sabatini | G. Manfroni | Serena Massari | O. Tabarrini | V. Cecchetti | M. Barreca | R. Cannalire | T. Felicetti | Maria Sole Burali
[1] G. Kaatz,et al. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors. , 2017, Journal of medicinal chemistry.
[2] L. Goracci,et al. Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study. , 2016, Journal of medicinal chemistry.
[3] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[4] F. Bucar,et al. Plant derived inhibitors of bacterial efflux pumps: an update , 2015, Phytochemistry Reviews.
[5] Aurélien Lesnard,et al. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives. , 2015, European journal of medicinal chemistry.
[6] Aurélien Lesnard,et al. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. , 2014, Journal of medicinal chemistry.
[7] G. Kaatz,et al. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance. , 2013, Journal of medicinal chemistry.
[8] J. Handzlik,et al. Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus , 2013, Antibiotics.
[9] N. T. Patil,et al. Enantioselective cooperative triple catalysis: unique roles of Au(I)/amine/chiral Brønsted acid catalysts in the addition/cycloisomerization/transfer hydrogenation cascade. , 2013, Chemical communications.
[10] A. Oliver,et al. High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms , 2012, Antimicrobial Agents and Chemotherapy.
[11] M. Otto. MRSA virulence and spread , 2012, Cellular microbiology.
[12] G. Kaatz,et al. Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives , 2012 .
[13] K. Varani,et al. 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists. , 2012, Journal of medicinal chemistry.
[14] Xiaomei Zhang,et al. Lewis Base Organocatalyzed Enantioselective Hydrosilylation of 1,4-Benzoxazines , 2012, Synlett.
[15] E. Carosati,et al. Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors. , 2012, Journal of medicinal chemistry.
[16] G. Cruciani,et al. Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA. , 2012, ACS medicinal chemistry letters.
[17] B. Schmidt,et al. Oxidative Homologation of Aldehydes to α‐Ketoaldehydes by using Iodoform, o‐Iodoxybenzoic Acid, and Dimethyl Sulfoxide , 2012 .
[18] G. Kaatz,et al. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. , 2011, Journal of medicinal chemistry.
[19] Stefano Sabatini,et al. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. , 2011, Journal of medicinal chemistry.
[20] G. Kaatz,et al. Ethidium Bromide MIC Screening for Enhanced Efflux Pump Gene Expression or Efflux Activity in Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.
[21] M. Rueping,et al. Asymmetric Brønsted acid catalysis in aqueous solution , 2010 .
[22] Lee H. Harrison,et al. Health care-associated invasive MRSA infections, 2005-2008. , 2010, JAMA.
[23] Ling Zhang,et al. Efflux Pump Inhibitors: A Strategy to Combat P‐Glycoprotein and the NorA Multidrug Resistance Pump , 2010, ChemMedChem.
[24] E. Carosati,et al. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps. , 2010, Journal of medicinal chemistry.
[25] M. Rueping,et al. The first general, efficient and highly enantioselective reduction of quinoxalines and quinoxalinones. , 2010, Chemistry.
[26] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[27] H. Nikaido,et al. Efflux-Mediated Drug Resistance in Bacteria , 2009, Drugs.
[28] F. Verpoort,et al. Base-mediated synthesis of quinolines: an unexpected cyclization reaction between 2-aminobenzylalcohol and ketones , 2008 .
[29] A. Hidrón,et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.
[30] Viktoria Hancock,et al. Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation , 2008, Applied and Environmental Microbiology.
[31] D. Payne. Desperately Seeking New Antibiotics , 2008, Science.
[32] Joseph I. Ambrus,et al. Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus. , 2008, Bioorganic & medicinal chemistry letters.
[33] Gary Taubes,et al. The Bacteria Fight Back , 2008, Science.
[34] G. Kaatz,et al. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. , 2008, Journal of medicinal chemistry.
[35] S. Zaher. Clinical Infectious Disease , 2008 .
[36] Roberta B Carey,et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.
[37] A. Shorr. Epidemiology of staphylococcal resistance. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] L. Piddock,et al. Bacterial efflux pump inhibitors from natural sources. , 2007, The Journal of antimicrobial chemotherapy.
[39] Jean-Marie Pagès,et al. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. , 2007, The Journal of antimicrobial chemotherapy.
[40] J. Weber. Community-associated methicillin-resistant Staphylococcus aureus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] W. Jarvis,et al. Has methicillin-resistant Staphylococcus aureus stopped spreading in intensive care units? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] C. Cho,et al. Consecutive isomerization and cyclization of 3-(2-aminophenyl)-1-arylprop-2-yn-1-ols leading to 2-arylquinolines in the presence of potassium hydroxide , 2004 .
[43] S. Gibbons. Anti-staphylococcal plant natural products. , 2004, Natural product reports.
[44] H. Nikaido. Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.
[45] Alessandra Napolitano,et al. 1,4-benzothiazines as key intermediates in the biosynthesis of red hair pigment pheomelanins. , 2003, Pigment cell research.
[46] G. Kaatz,et al. Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. , 2003, International journal of antimicrobial agents.
[47] J. Ruiz. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. , 2003, The Journal of antimicrobial chemotherapy.
[48] G. Kaatz,et al. Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.
[49] R. SanMartin,et al. A Simple Route to New Phenanthro‐ and Phenanthroid‐Fused Thiazoles by a PIFA‐Mediated (Hetero)biaryl Coupling Reaction , 2002 .
[50] Claude Carbón. MRSA and MRSE: is there an answer? , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[51] G. Wright,et al. Resisting resistance: new chemical strategies for battling superbugs. , 2000, Chemistry & biology.
[52] M. Wahiduzzaman,et al. Evidence for the Existence of a Multidrug Efflux Transporter Distinct from NorA in Staphylococcus aureus , 2000, Antimicrobial Agents and Chemotherapy.
[53] G. Fabrizi,et al. The Palladium-Catalyzed Transfer Hydrogenation/Heterocyclization of β-(2-Aminophenyl)-α,β-ynones. An Approach to 2-Aryl- and 2-Vinylquinolines , 1999 .
[54] G. Kaatz,et al. Effects of NorA Inhibitors on In Vitro Antibacterial Activities and Postantibiotic Effects of Levofloxacin, Ciprofloxacin, and Norfloxacin in Genetically Related Strains ofStaphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.
[55] J. Verhoef,et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.
[56] K. Bush,et al. Bacterial enzymatic resistance: β-lactamases and aminoglycoside-modifying enzymes , 1998 .
[57] G. Kaatz,et al. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus , 1997, Antimicrobial agents and chemotherapy.
[58] R. Wise,et al. The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin. , 1997, The Journal of antimicrobial chemotherapy.
[59] S. Cenini,et al. Intramolecular amination catalysed by ruthenium and palladium. Synthesis of 2-acyl indoles and 2-aryl quinolines by carbonylation of 2-nitrochalcones , 1996 .
[60] S. Schuldiner,et al. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. , 1993, The Journal of biological chemistry.
[61] K. Entian,et al. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. , 1992, European journal of biochemistry.
[62] L. Reimer,et al. Antibiotics in laboratory medicine , 1987 .
[63] G. Sabitha,et al. Synthesis of 3-Arylcoumarins, 2-Aroylbenzofurans and 3-Aryl-2H-1,4-benzoazines Under Phase-Transfer Catalysis Conditions , 1987 .
[64] C. Iijima,et al. Quinoxalines. XXII. Aryl Migration of 2-Aroylquinoxalines to 2-Arylquinoxalines , 1985 .
[65] P. Battistoni,et al. A GENERAL METHOD FOR THE SYNTHESIS OF 3-PHENYL-2H-1,4-BENZOXAZINES AND 3-PHENYL-2H-3,4-DIHYDRO-1,4-BENZOXAZINES , 1979 .
[66] W. Ried,et al. Reaktionen mit Cyclobutendionen, XL. Ringöffnungsreaktionen des 3,4-Diphenyl-3-cyclobuten-1,2-dions mit dinucleophilen Agenzien , 1976 .
[67] S W B Newsom,et al. Antimicrobial Agents and Chemotherapy—1967 , 1966 .
[68] W. Horton,et al. Seven-membered Ring Compounds. VII.1 7-Acetamidobenzosuberone and α-Amino-γ-3,4,5-trimethoxyphenylbutyric Acid , 1954 .
[69] J. H. Boyer,et al. Azidocarbonyl Compounds. II. The Pyrolysis of α-Azidocarbonyl Compounds1a , 1953 .
[70] Dl Hoyert,et al. National Vital Statistics Reports NCHS.pdf , 2012 .
[71] Hiroshi Nikaido,et al. Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.
[72] J. Bartlett,et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] S. Leeder. World Health OrganizationWHO Library Cataloguing-in-Publication Data , 2004 .
[74] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[75] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[76] S. Goldstein,et al. 2-Substituted 1,2,3,4-Tetrahydroquinolines from Quinoline , 1989 .
[77] S. Murata,et al. Hydrogenation and hydrosilylation of quinoxaline by homogeneous rhodium catalysts , 1987 .
[78] P. Battistoni,et al. 3-phenyl-2H-1,4-benzoxazine-4-oxides—I : Synthesis and reduction , 1979 .
[79] G. Prota,et al. Oxidative behaviour of 3-aryl-2H-1,4-benzoxazines , 1976 .
[80] G. Lindstedt,et al. Attempts to Synthesize alpha-(3,4-Dimethoxyphenyl)glycerol Derivatives. , 1950 .
[81] F. M. Hamer,et al. 19. Thiazinocyanines. Part I. Carbocyanines containing the 2 : 4-benzthiazine nucleus , 1942 .